The biology of EBV infection in human epithelial cells

Seminars in Cancer Biology

Volumn 22, Issue 2, 2012, Pages 137-143

  Tsao, Sai Wah ^a   Tsang, Chi Man ^a   Pang, Pei Shin ^a   Zhang, Guitao ^a   Chen, Honglin ^a   Lo, Kwok Wai ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Biology of infection; EBV; Epithelial cells; Nasopharyngeal carcinoma

Indexed keywords

STAT3 PROTEIN; VIRUS PROTEIN;

B LYMPHOCYTE; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; EPITHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSURVEILLANCE; LYMPHOBLASTOID CELL; MONONUCLEOSIS; NASOPHARYNX CARCINOMA; ONCOGENE; PATHOGENESIS; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TROPISM; UPREGULATION;

EID: 84862816141     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2012.02.004     Document Type: Review

References (70)

1. Kieff E., Rickinson A.B. Epstein-Barr virus and its replication. Fields virology 2007, 2603-2655. Lippincott Williams & Wilkins Press. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
2. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields virology 2007, 2655-2700. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
3. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:702-703.
4. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768.
5. Thorley-Lawson D.A. EBV persistence and latent infection in vivo. Epstein Barr virus 2005, 309-358. Casister Academic Press. E.S. Robertson (Ed.).
6. Diehl V., Henle G., Henle W., Kohn G. Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol 1968, 2:663-669.
7. Hadinoto V., Shapiro M., Sun C.C., Thorley-Lawson D.A. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 2009, 5:e1000496.
8. Nemerow G.R., Wolfert R., McNaughton M.E., Cooper N.R. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 1985, 55:347-351.
9. Chesnokova L.S., Hutt-Fletcher L.M. Fusion of Epstein-Barr virus with epithelial cells can be triggered by alphavbeta5 in addition to alphavbeta6 and alphavbeta8, and integrin binding triggers a conformational change in glycoproteins gHgL. J Virol 2011, 85:13214-13223.
10. Chesnokova L.S., Nishimura S.L., Hutt-Fletcher L.M. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc Natl Acad Sci USA 2009, 106:20464-20469.
11. Zur H.H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970, 228:1056-1058.
12. Lo Y.M. Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring. Ann N Y Acad Sci 2001, 945:68-72.
13. Wei M.X., Ooka T. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J 1989, 8:2897-2903.
14. Decaussin G., Sbih-Lammali F., de Turenne-Tessier M., Bouguermouh A., Ooka T. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 2000, 60:5584-5588.
15. Al-Mozaini M., Bodelon G., Karstegl C.E., Jin B., Al-Ahdal M., Farrell P.J. Epstein-Barr virus BART gene expression. J Gen Virol 2009, 90:307-316.
16. Feederle R., Linnstaedt S.D., Bannert H., Lips H., Bencun M., Cullen B.R., et al. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 2011, 7:e1001294.
17. Lo K.W., To K.F., Huang D.P. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5:423-428.
18. Li Q.X., Young L.S., Niedobitek G., Dawson C.W., Birkenbach M., Wang F., et al. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 1992, 356:347-350.
19. Knox P.G., Li Q.X., Rickinson A.B., Young L.S. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology 1996, 215:40-50.
20. Sixbey J.W., Yao Q.Y. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992, 255:1578-1580.
21. Lin C.T., Lin C.R., Tan G.K., Chen W., Dee A.N., Chan W.Y. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 1997, 150:1745-1756.
22. Wu H.C., Lin Y.J., Lee J.J., Liu Y.J., Liang S.T., Peng Y., et al. Functional analysis of EBV in nasopharyngeal carcinoma cells. Lab Invest 2003, 83:797-812.
23. Teramoto N., Maeda A., Kobayashi K., Hayashi K., Oka T., Takahashi K., et al. Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity. Lab Invest 2000, 80:303-312.
24. Hutt-Fletcher L., Lake C.M. Two Epstein-Barr virus glycoprotein complexes. Epstein-Barr virus and human cancers 2001, 51-64. Springer. K. Takada (Ed.).
25. Borza C.M., Hutt-Fletcher L.M. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 2002, 8:594-599.
26. Hutt-Fletcher L. EBV entry and epithelial infection. Epstein-Barr virus 2005, 359-378. Academic Press, Casister. E.S. Robertson (Ed.).
27. Imai S., Nishikawa J., K.Takada Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 1998, 72:4371-4378.
28. Chang Y., Tung C.H., Huang Y.T., Lu J., Chen J.Y., Tsai C.H. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 1999, 73:8857-8866.
29. Hui K.F., Chiang A.K. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death. Int J Cancer 2010, 126:2479-2489.
30. Shannon-Lowe C.D., Neuhierl B., Baldwin G., Rickinson A.B., Delecluse H.J. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 2006, 103:7065-7070.
31. Shannon-Lowe C., Rowe M. Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. PLoS Pathog 2011, 7:e1001338.
32. Sixbey J.W., Nedrud J.G., N.Raab-Traub, Hanes R.A., Pagano J.S. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984, 310:1225-1230.
33. Sixbey J.W., Vesterinen E.H., Nedrud J.G., Raab-Traub N., Walton L.A., Pagano J.S. Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 1983, 306:480-483.
34. Corso B., Eversole L.R., Hutt-Fletcher L. Hairy leukoplakia: Epstein-Barr virus receptors on oral keratinocyte plasma membranes. Oral Surg Oral Med Oral Pathol 1989, 67:416-421.
35. Tugizov S.M., Berline J.W., Palefsky J.M. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 2003, 9:307-314.
36. Pegtel D.M., Subramanian A., Meritt D., Tsai C.H., Sheen T.S., Golub T.R., et al. IFN-alpha-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas. Cancer Res 2007, 67:474-481.
37. Feederle R., Neuhierl B., Bannert H., Geletneky K., Shannon-Lowe C., Delecluse H.J. Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 2007, 121:588-594.
38. Lechner J.F., Haugen A., Autrup H., McClendon I.A., Trump B.F., Harris C.C. Clonal growth of epithelial cells from normal adult human bronchus. Cancer Res 1981, 41:2294-2304.
39. Fung L.F., Yuen P.W., Wei W., Kwan H.S., Tsao S.W. Identification of genes differentially expressed in nasopharyngeal carcinoma by messenger RNA differential display. Int J Oncol 1998, 13:85-89.
40. Fung L.F., Lo A.K., Yuen P.W., Liu Y., Wang X.H., S.W.Tsao Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 2000, 67:923-936.
41. Li H.M., Man C., Jin Y., Deng W., Yip Y.L., Feng H.C., et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer 2006, 119:1567-1576.
42. Tsao S.W., Wang X., Liu Y., Cheung Y.C., Feng H., Zheng Z., et al. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 2002, 1590:150-158.
43. Lo A.K., Lo K.W., Tsao S.W., Wong H.L., Hui J.W., To K.F., et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 2006, 8:173-180.
44. Wong H.L., Wang X., Chang R.C., Jin D.Y., Feng H., Wang Q., et al. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol Carcinog 2005, 44:92-101.
45. Tsang C.M., Zhang G., Seto E., Takada K., Deng W., Yip Y.L., et al. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. Int J Cancer 2010, 127:1570-1583.
46. Hsiao J.R., Chang K.C., Chen C.W., Wu S.Y., Su I.J., Hsu M.C., et al. Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma. Cancer Res 2009, 69:4461-4467.
47. Ahsan N., Kanda T., Nagashima K., Takada K. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J Virol 2005, 79:4415-4424.
48. Shannon-Lowe C., Adland E., Bell A.I., Delecluse H.J., Rickinson A.B., Rowe M. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 2009, 83:7749-7760.
49. Leight E.R., Sugden B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 2001, 21:4149-4161.
50. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Dahl D.B., Chen M., et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res 2006, 66:7999-8006.
51. Huang Y.T., Sheen T.S., Chen C.L., Lu J., Chang Y., Chen J.Y., et al. Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. Cancer Res 1999, 59:1599-1605.
52. Chen H., Hutt-Fletcher L., Cao L., Hayward S.D. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol 2003, 77:4139-4148.
53. Israel B.F., Kenney S.C. EBV lytic infection. Epstein Barr virus 2005, 571-612. Casister Academic Press. E.S. Robertson (Ed.).
54. Hui A.B., Or Y.Y., Takano H., Tsang R.K., To K.F., Guan X.Y., et al. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005, 65:8125-8133.
55. Morris M.A., Dawson C.W., Young L.S. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol 2009, 5:811-825.
56. Kondo S., Wakisaka N., Muramatsu M., Zen Y., Endo K., Murono S., et al. Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines. J Virol 2011, 85:11255-11264.
57. Kong Q.L., Hu L.J., Cao J.Y., Huang Y.J., Xu L.H., Liang Y., et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010, 6:e1000940.
58. Seto E., Ooka T., Middeldorp J., Takada K. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res 2008, 68:1030-1036.
59. Seto E., Yang L., Middeldorp J., Sheen T.S., Chen J.Y., Fukayama M., et al. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol 2005, 76:82-88.
60. Chen H., Lee J.M., Zong Y., Borowitz M., Ng M.H., Ambinder R.F., et al. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol 2001, 75:2929-2937.
61. Gruhne B., Sompallae R., Marescotti D., Kamranvar S.A., Gastaldello S., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci USA 2009, 106:2313-2318.
62. Sivachandran N., Dawson C.W., Young L.S., Liu F.F., Middeldorp J., Frappier L. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol 2012, 86:60-68.
63. Lee C.P., Chen J.Y., Wang J.T., Kimura K., Takemoto A., Lu C.C., et al. Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II. J Virol 2007, 81:5166-5180.
64. Wu C.C., Liu M.T., Chang Y.T., Fang C.Y., Chou S.P., Liao H.W., et al. Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells. Nucleic Acids Res 2010, 38:1932-1949.
65. Choy E.Y., Siu K.L., Kok K.H., Lung R.W., Tsang C.M., To K.F., et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 2008, 205:2551-2560.
66. Ellis-Connell A.L., Iempridee T., Xu I., Mertz J.E. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J Virol 2010, 84:10329-10343.
67. Yu X., Wang Z., Mertz J.E. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog 2007, 3:e194.
68. Ma S.D., Hegde S., Young K.H., Sullivan R., Rajesh D., Zhou Y., et al. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol 2011, 85:165-177.
69. Fang C.Y., Lee C.H., Wu C.C., Chang Y.T., Yu S.L., Chou S.P., et al. Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. Int J Cancer 2009, 124:2016-2025.
70. Iempridee T., Das S., Xu I., Mertz J.E. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene. J Virol 2011, 85:7836-7848.